Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

URGN holding history

UroGen Pharma Ltd. in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

URGN overviewAll 13F holders of URGNFull Q2 2026 holdings

Shares (Q2 2026)
197,098
Value
$7.25M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of URGN by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026197,098$7.25M<0.1%+52,137+36.0%AddedHolders
Q1 2026144,961$2.61M<0.1%+21,398+17.3%AddedHolders
Q4 2025123,563$2.89M<0.1%+50,447+69.0%AddedHolders
Q3 202573,116$1.46M<0.1%+70,726+2,959.2%AddedHolders
Q2 20252,390$32.7K<0.1%−510−17.6%ReducedHolders
Q1 20252,900$32.1K<0.1%−17,071−85.5%ReducedHolders
Q4 202419,971$212.7K<0.1%−3,119−13.5%ReducedHolders
Q3 202423,090$293.2K<0.1%+19,670+575.1%AddedHolders
Q2 20243,420$57.4K<0.1%+189+5.8%AddedHolders
Q1 20243,231$48.5K<0.1%−1,649−33.8%ReducedHolders
Q4 20234,880$73.2K<0.1%−39−0.8%ReducedHolders
Q3 20234,919$68.9K<0.1%+4,416+877.9%AddedHolders
Q2 2023503$5.21K<0.1%+49+10.8%AddedHolders
Q1 2023454$4.20K<0.1%00.0%UnchangedHolders
Q4 2022454$4.03K<0.1%00.0%UnchangedHolders
Q3 2022454$4.00K<0.1%−86−15.9%ReducedHolders
Q2 2022540$4.00K<0.1%+244+82.4%AddedHolders
Q1 2022296$3.00K<0.1%+296NewHolders
Q3 20210$00.0%−47,603−100.0%Sold outHolders
Q2 202147,603$727.0K<0.1%00.0%UnchangedHolders
Q1 202147,603$927.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.